The mission of the Practice Harmonisation and Guidelines Committee (PH&G) is to develop, publish, and continuously improve state-of-the-art clinical guidelines and harmonisation initiatives that support high quality, equitable, and effective transplantation and cellular therapy practices across the EBMT and wider global community.
Practice Harmonisation Committee Team
Practice Harmonisation & Guidelines Committee Chair
United Kingdom
Practice Harmonisation & Guidelines Committee Vice-Chair
Italy
SCIENTIFIC COUNCIL REPRESENTATIVE WITH THE EDUCATION PORTFOLIO
Practice Harmonisation & Guidelines Committee Educational Representative
LWP Chair
Lebanon
Chief Medical Officer
Education Director
Practice Harmonisation and Guidelines Committee Secretary
Barcelona,
Spain
Committee Objectives
- Develop and maintain high-quality, practical and evidence-based clinical guidelines for transplantation and cellular therapy practice.
- Promote harmonisation of clinical practice across EBMT member centres and wider globally.
- Improve implementation, accessibility, and uptake of EBMT recommendations.
- Support data-driven quality improvement and outcome-based practice optimisation across centres.
- Address emerging therapies and rapidly evolving areas of clinical practice by rapid generation of guidance.
- Foster multidisciplinary collaboration, education, and stakeholder engagement.
- Ensure transparent governance, methodological rigor, and continuous evaluation of committee activities and productivity.
Activities
- Provide oversight and guidance of the expert development of all practice harmonisation (PH) and guideline (G) topics on behalf of the EBMT.
- Liaise with WP chairs and other multidisciplinary experts leading workshops within the EBMT to select key topics for each edition of the PH&G meetings and to aid selection of additional potential experts where required.
- Monitor evolving international clinical practices and ensure timely review and updating of already published practice harmonisation documents and guidelines.
- Contribute to the scientific and strategic direction of the EBMT, including the development and refinement of relevant guidelines and policies related to practice harmonisation and guideline generation.
- Engage with Corporate Patrons, partners, and sponsors to provide scientific expertise and support initiatives that advance EBMT objectives and activities regarding practice harmonisation.
Strategy
Strategic Goals 2026-2030
To fulfil our mission and meet our committee objectives, the committee has identified the following strategic priorities for the current term:
- Increase number of publications from the committee per annum with annual audit of practice.
- Rapid-Response Frameworks for practice guidelines where required: Establish a "Fast-Track" guidance generation pathway within the committee for emerging cellular and gene therapies This goal ensures that the EBMT remains one of the primary authorities for safe and effective practice guidance and harmonisation as soon as new treatments receive approval.
- "Practice Gap" Initiative: Our goal is to identify barriers to harmonization uptake and receive feedback on improvements and applicability on a global scale.
- Patient-Advocate and wider multi-disciplinary team integration into guidance generation: Formally integrate patient and donor representatives into the guideline development process where appropriate for the topic.
